XML 35 R24.htm IDEA: XBRL DOCUMENT v3.25.0.1
LONG-TERM DEBT (Notes)
 3 Months Ended
Jan. 31, 2025
Debt Disclosure [Abstract]  
LONG-TERM DEBT LONG-TERM DEBT
Senior Notes
 
The following table summarizes the company’s long-term senior notes:
 
 January 31, 2025October 31, 2024
 Amortized
Principal		Amortized
Principal
(in millions)
2026 Senior Notes$299 $299 
2027 Senior Notes596 596 
2029 Senior Notes496 496 
2030 Senior Notes497 497 
2031 Senior Notes845 845 
2034 Senior Notes593 593 
Total Senior Notes$3,326 $3,326 


All outstanding notes listed above are unsecured and rank equally in right of payment with all of Agilent’s other senior unsecured indebtedness. There have been no other changes to the principal, maturity, interest rates and interest payment terms of the Agilent senior notes, detailed in the table above, in the three months ended January 31, 2025, as compared to the senior notes described in our Annual Report on Form 10-K for the fiscal year ended October 31, 2024.
Other Loans
In connection with the BIOVECTRA acquisition, we have two interest-free loans from the Strategic Innovation Fund ("SIF"). The loans are repayable in quarterly and yearly installments through 2040 at a weighted average imputed interest rate of 4.7 percent. In addition, we have two interest-free loans with the Atlantic Canada Opportunities Agency (“ACOA”). The loans are repayable in monthly installments through 2029 at a weighted average imputed interest rate of 4.5 percent. As of January 31, 2025 and October 31, 2024, the non-current portion of these loans of $21 million (including additional draw and measurement period adjustment) and $19 million, respectively, was recorded in long-term debt.